Dae-Eun Kim Selected Research

Dae-Eun Kim Research Topics

Disease

9	Neoplasms (Cancer) 10/2018 - 11/2011
5	Neoplasm Metastasis (Metastasis) 10/2018 - 11/2011
4	Stomach Neoplasms (Stomach Cancer) 03/2013 - 11/2011
3	Inflammation (Inflammations) 01/2019 - 10/2014
2	Cicatrix (Scar) 02/2021 - 03/2016
2	Colonic Neoplasms (Colon Cancer) 05/2013 - 11/2011
2	Adenocarcinoma 10/2012 - 11/2011
1	Neuroinflammatory Diseases 02/2024
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 02/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Obesity 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2017
1	Heart Injuries 05/2017
1	Dementia (Dementias) 10/2014
1	Malaria 10/2014
1	Ischemia 05/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2013
1	Esophageal Neoplasms (Esophageal Cancer) 12/2013
1	Hypoxia (Hypoxemia) 03/2013
1	Hemorrhage 08/2012
1	Xerostomia 08/2012
1	Flatulence 08/2012
1	Pain (Aches) 08/2012
1	Hypoalbuminemia 11/2011
1	Aspirin-Induced Asthma 09/2010
1	Respiratory Hypersensitivity 09/2010

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 02/2024 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2013
2	Docetaxel (Taxotere)FDA Link 01/2013 - 11/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2024
1	graphene oxideIBA 02/2021
1	Cysteamine (Mercaptamine)FDA Link 02/2019
1	apelin-12 peptideIBA 01/2019
1	AdipokinesIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 10/2018
1	Peptide Hydrolases (Proteases)FDA Link 10/2018
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2018
1	2- (methoxycarbonyl(4- methoxyphenyl)methylsulfanyl)- 1H- benzimidazole- 4- carboxylic acid amideIBA 05/2017
1	CollagenIBA 03/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015
1	artemisinin (artemisinine)IBA 10/2014
1	hispidinIBA 10/2014
1	rhamnetinIBA 05/2014
1	PlatinumIBA 12/2013
1	HLA-A*02:01 antigenIBA 05/2013
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 05/2013
1	EpitopesIBA 05/2013
1	Peptides (Polypeptides)IBA 05/2013
1	AntigensIBA 05/2013
1	Galectin 3 (LGALS3)IBA 05/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2013
1	TubulinIBA 03/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2013
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013
1	Poloxamer (Poloxamer 407)IBA 01/2013
1	HydrogelsIBA 01/2013
1	Conjugated Linoleic AcidsIBA 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 11/2012
1	Capecitabine (Xeloda)FDA Link 10/2012
1	titanium silicide (TS-1)IBA 10/2012
1	Chewing Gum (Chewing Gums)IBA 08/2012
1	Analgesics (Analgesic Drugs)IBA 08/2012
1	Narcotics (Narcotic Analgesics)IBA 08/2012
1	Indicators and Reagents (Reagents)IBA 11/2011
1	AlbuminsIBA 11/2011
1	TetraspaninsIBA 11/2011
1	Firefly LuciferasesIBA 11/2011
1	Small Interfering RNA (siRNA)IBA 11/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2010
1	Methacholine Chloride (Methacholine)FDA Link 09/2010

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2013 - 11/2011
2	Chemoradiotherapy 12/2013 - 11/2012
2	Therapeutics 01/2013 - 11/2011
1	Microspheres (Microsphere) 10/2018
1	Neoadjuvant Therapy 12/2013
1	Immunotherapy 05/2013
1	Combination Drug Therapy (Combination Chemotherapy) 10/2012
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 08/2012
1	Early Ambulation 08/2012
1	Bed Rest (Bedrest) 08/2012
1	Intravenous Administration 11/2011